Management of Moderately Hypoxemic Thoracic Trauma

NAActive, not recruitingINTERVENTIONAL
Enrollment

770

Participants

Timeline

Start Date

November 12, 2019

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Chest TraumaHigh Flow Oxygenation
Interventions
DEVICE

High flow Oxygenation

Interventional group: All patients included in this group will receive a continuous heated and humidified high-flow (30 to 60 l/min) oxygenation with a nasal cannula for 48 hours. Initially, flow rate will be started at 50 l/min with a FiO2 at 50%. According to the protocol, flow rate and FiO2 will be titrated on SpO2 and respiratory tolerance. Weaning and failure of high-flow oxygenation are described in detail in the study protocol.

DEVICE

Standard oxygen

Control group: All patients included in this group will receive a low flow oxygenation (flow rate \< 15 l/min) with nasal cannula (flow rate ≤ 6 l/min) or non-rebreathing mask (flow rate ≥ 7 l/min).

Trial Locations (18)

13005

La Timone Hospital (AP-HM), Marseille

28000

Chartres Hospital, Chartres

29000

Centre Hospitalier de Cornouaille, Quimper

29200

CHU de Brest, Brest

34295

CHRU de Montpellier, Montpellier

35000

Rennes, university Hospital, Rennes

56017

CHBA de Vannes, Vannes

56100

Centre Hospitalier de Bretagne Sud, Lorient

75651

CHRU de la Pitié-Salpétrière, Paris

92141

HIA Percy, Clamart

Unknown

Angers university hospital, Angers

Dreux hospital, Dreux

Le Mans hospital, Le Mans

Marseille university horpital, Marseille

Morlaix hospital, Morlaix

Nantes university hospital, Nantes

Kremlin Bicêtre university hospital (APHP), Paris

Tours university hospital, Tours

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT03997630 - Management of Moderately Hypoxemic Thoracic Trauma | Biotech Hunter | Biotech Hunter